• Sensex78205.98639.82(0.82%)
  • Nifty24291.35263.3(1.1%)
  • USDINR91.63-0.66(-0.71%)
Online tarding Partner With Us
BSE Prices delayed by 5 minutes ! Prices as on   Mar 10, 2026 - 3:38PM   ABB India 6235 [ 4.28% ]ACC 1479 [ 1.89% ]Ambuja Cements 462.1 [ 2.31% ]Asian Paints 2290 [ 3.13% ]Axis Bank 1318.8 [ 2.36% ]Bajaj Auto 9590 [ 2.25% ]Bank of Baroda 295.4 [ 2.52% ]Bharti Airtel 1855.7 [ -0.61% ]Bharat Heavy 259 [ 1.47% ]Bharat Petroleum 327 [ -1.24% ]Britannia Industries 5977.45 [ 1.62% ]Cipla 1335.7 [ 0.80% ]Coal India 443.8 [ 1.39% ]Colgate Palm 2204.4 [ 2.31% ]Dabur India 481.1 [ 3.10% ]DLF 583.65 [ 1.56% ]Dr. Reddy's Lab. 1315.7 [ 2.28% ]GAIL (India) 150.5 [ 1.07% ]Grasim Industries 2754.5 [ 2.78% ]HCL Technologies 1363.5 [ 0.36% ]HDFC Bank 849 [ 1.17% ]Hero MotoCorp 5713.35 [ 4.21% ]Hindustan Unilever 2191.85 [ -0.10% ]Hindalco Industries 957.9 [ 1.31% ]ICICI Bank 1313 [ 2.79% ]Indian Hotels Co. 629.85 [ 2.95% ]IndusInd Bank 897.35 [ 1.82% ]Infosys 1296 [ -1.40% ]ITC 309.15 [ 1.00% ]Jindal Steel 1185.1 [ 3.55% ]Kotak Mahindra Bank 392.4 [ 1.53% ]L&T 3882.6 [ 1.11% ]Lupin 2344 [ 1.84% ]Mahi. & Mahi 3304.1 [ 3.67% ]Maruti Suzuki India 13901.2 [ 2.94% ]MTNL 26.5 [ 4.45% ]Nestle India 1239 [ 0.23% ]NIIT 65.25 [ 4.48% ]NMDC 79.55 [ 0.58% ]NTPC 377.7 [ 0.33% ]ONGC 270 [ -0.02% ]Punj. NationlBak 117.75 [ 2.21% ]Power Grid Corpn. 299.5 [ 1.44% ]Reliance Industries 1411.5 [ -0.91% ]SBI 1114 [ 1.39% ]Vedanta 721.7 [ 1.75% ]Shipping Corpn. 244.6 [ 5.16% ]Sun Pharmaceutical 1810.55 [ 0.16% ]Tata Chemicals 692.8 [ -0.66% ]Tata Consumer Produc 1098.5 [ -0.23% ]Tata Motors Passenge 345 [ 3.93% ]Tata Steel 195.4 [ 2.28% ]Tata Power Co. 380 [ 1.90% ]Tata Consult. Serv. 2515 [ -0.50% ]Tech Mahindra 1342 [ 0.49% ]UltraTech Cement 11630 [ 2.23% ]United Spirits 1405.65 [ 3.74% ]Wipro 201 [ 1.21% ]Zee Entertainment 80.6 [ 0.83% ]
BSE

MARKETS

News Details

( As on 02/12/2025 13:17)

SPARC wins U.S. Court Ruling on Priority Review Voucher for Sezaby

Sun Pharma Advanced Research Company Ltd (SPARC) announced that the U.S. District Court for the District of Columbia has granted summary judgment in its favour regarding the issuance of a Priority Review Voucher (PRV) linked to the approval of Sezaby.

The court ruled that the U.S. FDA’s decision to withhold the PRV was unlawful, stating that “no drug product containing phenobarbital sodium was ‘previously approved’ as that term is used in the statute.” The ruling allows a 60-day window for appeal.

Commenting on the development, SPARC CEO Anil Raghavan said the decision reaffirms the company’s long-standing position on the matter.